CUVL

NASDAQ open

Clinuvel Pharmaceuticals

4.71 USD
0.000.00%
盘后 5.75 0.00%
2026-11-19
市值
$239.54M
市盈率
10.45
EPS
0.44
股息率
0.62%
52 周区间
4.71 – 8.92
成交量
1.56K
Beta
0.51
目标价
—
52W 低 4.7152W 高 8.92
价格走势

公司简介

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company’s pipeline products include CUV9900, an alpha-melanocyte stimulating hormone; and PRÉNUMBRA, a liquid injectable formulation of afame...